ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $726,000 | -1.4% | 497,000 | -4.1% | 0.00% | 0.0% |
| Q4 2016 | $736,000 | -22.8% | 518,400 | -4.8% | 0.00% | -50.0% |
| Q3 2016 | $953,000 | -4.2% | 544,800 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $995,000 | -15.8% | 582,100 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $1,182,000 | -2.2% | 600,200 | -5.7% | 0.00% | 0.0% |
| Q4 2015 | $1,209,000 | -0.5% | 636,300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,215,000 | -58.8% | 636,300 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $2,952,000 | -2.7% | 636,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $3,035,000 | 0.0% | 636,300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $3,035,000 | +13.8% | 636,300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,666,000 | -28.5% | 636,300 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $3,729,000 | -10.1% | 636,300 | -1.4% | 0.01% | -16.7% |
| Q1 2014 | $4,148,000 | +7.5% | 645,200 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $3,858,000 | +11.8% | 645,200 | -1.5% | 0.01% | 0.0% |
| Q3 2013 | $3,452,000 | -21.2% | 655,035 | +15.1% | 0.01% | -33.3% |
| Q2 2013 | $4,381,000 | – | 568,935 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |